MRI fat fraction imaging of nodal and bone metastases in prostate cancer

Cathy Qin; Olivia Goldberg; Geetanjali Kakar; Simon Wan; Athar Haroon; Aishah Azam; Sola Adeleke

doi:10.1007/s00330-023-09527-x

MRI fat fraction imaging of nodal and bone metastases in prostate cancer

Eur Radiol. 2023 Aug;33(8):5851-5855. doi: 10.1007/s00330-023-09527-x. Epub 2023 Mar 16.

Authors

Cathy Qin¹, Olivia Goldberg², Geetanjali Kakar², Simon Wan³, Athar Haroon⁴, Aishah Azam⁵, Sola Adeleke^{6

7}

Affiliations

¹ Department of Radiology, Imperial College Healthcare NHS Trust, London, UK. cathy.qin2@nhs.net.
² Department of Radiology, Imperial College Healthcare NHS Trust, London, UK.
³ Institute of Nuclear Medicine, University College London, London, UK.
⁴ Department of Nuclear Medicine, Bart's Health NHS Trust, London, UK.
⁵ Department of Radiology, Guy's and St Thomas' NHS Trust, London, UK.
⁶ Department of Oncology, Guy's and St Thomas' NHS Trust, London, UK.
⁷ School of Cancer and Pharmaceutical Sciences, Kings College London, London, UK.

PMID: 36928564
DOI: 10.1007/s00330-023-09527-x

Abstract

• Characterisation and quantification of tissue fat on MRI can be used to provide information on disease processes. • Fat in bone and lymph nodes up until recently have not been exploited for diagnostic purposes or response monitoring in prostate cancer. • Fat imaging on MRI using Dixon/PDFF sequences has the potential to add clinical value in the future but prospective data is needed.

Keywords: Bone marrow; Lymphatic metastasis; Magnetic resonance imaging; Prostate cancer.

Publication types

Editorial

MeSH terms

Bone Neoplasms* / diagnostic imaging
Bone Neoplasms* / secondary
Humans
Lymph Nodes
Magnetic Resonance Imaging / methods
Male
Prospective Studies
Prostatic Neoplasms* / diagnosis